During the past decade, Hospital San Pedro de Alcantara conducted 114 clinical trials. In the 10-year time frame, 114 clinical trials started and 32 clinical trials were completed, i.e. on average, 28.1% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 22 clinical trials were completed. i.e. 42.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital San Pedro de Alcantara" #1 sponsor was "PETHEMA Foundation" with 17 trials, followed by "Spanish Breast Cancer Research Group" with 8 trials sponsored, "Celgene" with 7 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "SOLTI Breast Cancer Research Group" with 7 trials sponsored. Other sponsors include 119 different institutions and companies that sponsored additional 92 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital San Pedro de Alcantara" #1 collaborator was "Novartis" with 5 trials as a collaborator, "Apices Soluciones S.L." with 4 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator and "Syntax for Science, S.L" with 3 trials as a collaborator. Other collaborators include 87 different institutions and companies that were collaborators in the rest 88 trials.

According to Clinical.Site data, the most researched conditions in "Hospital San Pedro de Alcantara" are "Breast Cancer" (15 trials), "Acute Myeloid Leukemia" (11 trials), "Coronary Artery Disease" (7 trials), "Leukemia, Myeloid, Acute" (6 trials) and "Myelodysplastic Syndromes" (5 trials). Many other conditions were trialed in "Hospital San Pedro de Alcantara" in a lesser frequency.

Most popular intervention types in "Hospital San Pedro de Alcantara" are "Drug" (126 trials), "Device" (13 trials), "Other" (13 trials), "Biological" (8 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Cytarabine" (10 trials), "Cyclophosphamide" (9 trials), "Paclitaxel" (9 trials) and "Trastuzumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hospital San Pedro de Alcantara" are 141 trials for "All" genders, 25 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital San Pedro de Alcantara". undefined are not yet recruiting, 37 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 80 completed trials in Hospital San Pedro de Alcantara, 1 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital San Pedro de Alcantara, 15 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 9 trials that are defined as “Not Applicable".

Hospital San Pedro de Alcantara has several departments that took part in Clinical trials: "Hospital San Pedro de Alcantara Servicio de Oncologia" - 15 trials, "Hospital San Pedro De Alcantara; Servicio de Hematologia" - 5 trials